All Articles by Author:

Bob

Cholesterol Dysregulation in APOE4 Astrocytes Promotes α-Synuclein Pathology in Mibrains

[Cell Stem Cell] The authors developed an iPSC-based 3D model that integrates neurons, glia, myelin, and cerebrovascular cells into a human brain-like tissue (“miBrain”). Single-nucleus RNA sequencing of miBrains confirmed the presence of diverse cell populations and revealed transcriptional responses to α-synuclein pathology.

A Bifunctional Optical Reporter for Tracking Estrogen Response Dynamics in Neurons

[Neuron] Scientists developed the fluorescent bifunctional reporter neuro-seeER, “see estrogen response”, that can be used to track changes in estrogen dynamics in vitro and in vivo, including longitudinally in behaving animals.

An Axon-Intrinsic Loop Restricts Nerve Regeneration through Axonal Protein Synthesis

[Science Advances] Researchers showed that local synthesis of Regenerating Family Member 3α, REG3A, in injured nerves activates translation of axonal KH-type splicing regulatory factor, Khsrp, mRNA in regenerating axons to slow peripheral nervous system nerve regeneration.

CUDC-907 Inhibits Glioblastoma and Enhances Glioblastoma Sensitivity to Temozolomide by Inhibiting DNA Damage Repair

[Genes & Diseases] The authors investigated the effects of CUDC-907 on glioblastoma using cellular, organoid, and animal models to assess its inhibitory potential and toxicity.

Nerve Growth Factor Receptor (NGFR): A Key Player in Glioblastoma Progression

[Biochimica Et Biophysica Acta-Reviews On Cancer] Investigators synthesize available literature on the role of the NGFR, particularly the p75 neurotrophin receptor, in glioblastoma progression.

Yale School of Medicine Awarded a Nearly $25 Million Grant to Map the Developing Brain and Advance Autism Research

[Yale School of Medicine] Yale School of Medicine received a grant of nearly $25 million from the Aligning Research to Impact Autism to map human brain development and investigate how and when autism diverges from typical development.

Popular

Challenges and Opportunities in Combining Radiotherapy and Immunotherapy for Localized Pancreatic Cancer

[Nature Reviews Gastroenterology & Hepatology] Expanding preclinical and clinical literature from PDAC and other oncological indications identifies novel approaches through which radiation therapy–immunotherapy combinations could improve local and systemic disease control in patients with PDAC.

Developmental and MAPK-Responsive Transcription Factors Regulate Distinct Malignant Cell States and Associated Genetic Dependencies in Pancreatic Cancer

[Nature Genetics] Single-cell master regulator analysis of multiple pancreatic ductal adenocarcinoma cohorts identified malignant cells in three co-existing, molecularly distinct developmental lineage states, with distinct histopathological morphologies and spatial architecture.

FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancer

[US FDA] The US FDA approved Rasonque (daraxonrasib), a RAS inhibitor for the most common form of pancreatic cancer—delivering a new treatment option to patients with advanced pancreatic cancer months ahead of schedule.